Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Strides Pharma Science Limited
  6. Company
    532531   INE939A01011


End-of-day quote Bombay Stock Exchange  -  2023-02-07
299.25 INR   -0.83%
01/25Strides Pharma Science Narrows Consolidated Loss in Fiscal Q3
01/24Transcript : Strides Pharma Science Limited, Q3 2023 Earnings Call, Jan 24, 2023
01/24Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Business Summary
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on development and manufacture of IP-led niche and pharmaceutical products. It operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Number of employees : 4 206 people.
Sales per Business
Pharmaceutical33 158.70100%30 702.50100% -7.41%
INR in Million
Sales per region
North America16 647.9050.2%12 059.0039.3% -27.56%
Europe7 324.9722.1%6 768.5522% -7.6%
Africa5 210.4115.7%5 707.4118.6% +9.54%
Australia2 452.867.4%3 174.7710.3% +29.43%
Asia (excluding India)623.141.9%1 970.596.4% +216.24%
India806.302.4%473.471.5% -41.28%
Others93.140.3%66.780.2% -28.3%
INR in Million
Name Title Age Since
Arun N. Kumar Executive Chairman & Chief Executive Officer 61 2022
Badree Komandur Group CFO, Finance Director & Executive Director - -
Anjani Kumar Chief Information Officer - -
Christoph Funke Chief Operating Officer - -
Manjula Ramamurthy Secretary & Compliance Officer - 2017
Umesh Pralhadrao Kale Chief Quality Services - -
Rahul Garella Chief Commercial Officer-International Markets 53 -
Sormistha Ghosh Chief Risk Officer & Group General Counsel - -
Tanaya Mishra, Dr. Chief Human Resource Officer - 2021
Members of the board
Name Title Age Since
Arun N. Kumar Executive Chairman & Chief Executive Officer 61 2022
Srinivasan Sridhar Independent Non-Executive Director 62 2012
Bharat Dhirajlal Shah Independent Non-Executive Director 75 2014
Homi Rustum Khusrokhan Independent Non-Executive Director 79 2017
Kausalya Santhanam, Dr. Independent Non-Executive Director 54 2019
Badree Komandur Group CFO, Finance Director & Executive Director - -
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 90,322,704 58,622,679 64.9% 0 0.0% 64.9%
Pronomz Ventures LLP 27,897,263 30.9%
Route One Investment Co. LP 6,675,046 7.39%
Aditya Birla Sun Life Amc Ltd. (Investment Management) 6,048,789 6.70%
SBI Funds Management Pvt Ltd. 4,578,618 5.07%
Life Insurance Corporation of India (Investment Portfolio) 4,459,806 4.94%
Capital Research & Management Co. (World Investors) 2,980,558 3.30%
quant Money Managers Ltd. 2,897,743 3.21%
Norges Bank Investment Management 2,060,565 2.28%
The Vanguard Group, Inc. 1,947,911 2.16%
Arun Kumar Pillai 1,840,997 2.04%
Company contact information
Strides Pharma Science Ltd.
Strides House
Bannerghatta Road
Bangalore, Karnataka 560076

Phone : +91.80.67840000
Fax : +91.80.67840700
Web : http://www.strides.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Strides Pharma Science Limited